| Javelin / Hospira Relationship Sours as Writs Fly EP Vantage submits:Having unceremoniously dumped Myriad Pharmaceuticals (MYRX) in favor of Hospira (HSO), Javelin Pharmaceuticals (JAV) is now finding out just how painful relationships can be (Javelin infidelity leaves Myriad looking for another partner, April 13, 2010). Thursday, Javelin announced that it was suing its new merger partner after Hospira extended the deadline of its $145m tender offer for Javelin shares for the second time from June 2 to June 16. What might be forcing Javelin to take such drastic action is fear of the consequences if a deal does not go through. The group is almost certainly running on fumes when it comes to cash and desperately needs an additional $2m loan from Hospira that would have come as part of the end of the tender offer and was payable on June 1. Complete Story » seekingalpha.com |
Biogen Names Scangos as CEO Biogen Idec named George Scangos as chief executive, hiring him away from the same role at smaller drug developer Exelixis. online.wsj.com |
Genzyme, Sanofi at Odds Over Threshold Price Genzyme and France's Sanofi-Aventis are still talking about a takeover of the U.S. biotech firm, but they remain at odds about a price at which Sanofi could begin due diligence. online.wsj.com |
Biogen Idec: A High Value, High Profit Stock John Mylant submits: Biogen Idec Inc. (BIIB) Sector: Healthcare Industry: BiotechnologyComplete Story » seekingalpha.com |
St. Joseph's / Phoenix Children's form Alliance - Video St. Joseph’s, Phoenix Children’s Negotiating Strategic Alliance for Pediatric Care feedproxy.google.com |